Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Mirador Therapeutics, Inc.

News headline image
Mirador Therapeutics Expands Precision Immunology Portfolio with Exclusive License to KP-301, a Long-Acting Anti-C5a Antibody
From Mirador Therapeutics, Inc.
Via Business Wire
News headline image
Mirador Accelerates Multi-Asset Clinical Pipeline in Immuno-Fibrotic Disease; Closes $250 Million Series B with Premier Investors
From Mirador Therapeutics, Inc.
Via Business Wire
News headline image
Mirador Therapeutics Appoints Gregg Gilbert as Chief Financial Officer
From Mirador Therapeutics, Inc.
Via Business Wire
News headline image
Mirador Therapeutics Launches to Accelerate the Next Generation of Precision Medicines for Immune-mediated Diseases
From Mirador Therapeutics, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.